Keith W. Ward

858 citations

19 papers · 584 indexed · h-index 14

Co-authors: Joel W. Proksch Karen Harrington Afshin Shafiee Brian R. Smith Claudio Bucolo Jean-Yves Driot David J. McCanna Leonard M. Azzarano
Topics: Antibiotics Pharmacokinetics and Efficacy (5 papers)Ocular Surface and Contact Lens (5 papers)Corneal Surgery and Treatments (4 papers)
Cited by: Ophthalmology Pharmacology Immunology
Journals: The Journal of Immunology Environmental Health Perspectives Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States France Australia

In The Last Decade

Keith W. Ward

19 papers receiving 556 citations

Peers

Countries citing papers authored by Keith W. Ward

Since Specialization

Citations

This map shows the geographic impact of Keith W. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith W. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith W. Ward more than expected).

Fields of papers citing papers by Keith W. Ward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith W. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith W. Ward. The network helps show where Keith W. Ward may publish in the future.

Co-authorship network of co-authors of Keith W. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Keith W. Ward. A scholar is included among the top collaborators of Keith W. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith W. Ward. Keith W. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy 2016 ·Clinical Science ·Devy Deliyanti,Jae‐Young Lee,Steven Petratos,Colin J. Meyer,Keith W. Ward,Jennifer L. Wilkinson‐Berka,Judy B. de Haan	29
2	Ocular Pharmacokinetics of Mapracorat, a Novel, Selective Glucocorticoid Receptor Agonist, in Rabbits and Monkeys 2011 ·Drug Metabolism and Disposition ·Joel W. Proksch,Ezra R. Lowe,Keith W. Ward	8
3	Ocular Pharmacokinetics/Pharmacodynamics of Besifloxacin, Moxifloxacin, and Gatifloxacin Following Topical Administration to Pigmented Rabbits 2010 ·Journal of Ocular Pharmacology and Therapeutics ·Joel W. Proksch,Keith W. Ward	24
4	In Vivo Ocular Efficacy Profile of Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, in Rabbit Models of Ocular Disease 2010 ·Investigative Ophthalmology & Visual Science ·Afshin Shafiee,Claudio Bucolo,Ewa Budzynski,Keith W. Ward,Francisco J. López	52
5	Ocular Pharmacokinetics of Besifloxacin Following Topical Administration to Rabbits, Monkeys, and Humans 2009 ·Journal of Ocular Pharmacology and Therapeutics ·Joel W. Proksch,Camille Granvil,(unknown),Timothy L. Comstock,Michael R. Paterno,Keith W. Ward	52
6	Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug–drug interactions 2009 ·Xenobiotica ·Keith W. Ward,(unknown),(unknown),(unknown),(unknown),Matthew S. Lawrence	5
7	Comparison of the effect of multipurpose contact lens solutions on the viability of cultured corneal epithelial cells 2009 ·Contact Lens and Anterior Eye ·Megan E. Cavet,Karen Harrington,Karl R. VanDerMeid,Keith W. Ward,Jin-Zhong Zhang	40
8	Rabbit Models of Contact Lens–Associated Corneal Hypoxia: A Review of the Literature 2008 ·Eye & Contact Lens Science & Clinical Practice ·David J. McCanna,Jean-Yves Driot,(unknown),Keith W. Ward	15
9	Experimental determination and allometric prediction of vitreous volume, and retina and lens weights in Göttingen minipigs 2008 ·Veterinary Ophthalmology ·Afshin Shafiee,(unknown),(unknown),Keith W. Ward	13
10	Use of a Human Corneal Epithelial Cell Line for Screening the Safety of Contact Lens Care Solutions In Vitro 2007 ·Eye & Contact Lens Science & Clinical Practice ·David J. McCanna,Karen Harrington,Jean-Yves Driot,Keith W. Ward,Ruy Tchao	37
11	Cassette Dosing Pharmacokinetic Studies for Evaluation of Ophthalmic Drugs for Posterior Ocular Diseases 2007 ·Journal of Pharmaceutical Sciences ·Joel W. Proksch,Keith W. Ward	6
12	Development and validation of an RP‐HPLC‐UV method for the determination of BOL‐303225‐A, a new coumarin‐based anti‐inflammatory drug, in rat plasma 2007 ·Biomedical Chromatography ·Adriana Maltese,(unknown),Keith W. Ward,Claudio Bucolo	7
13	Apparent absolute oral bioavailability in excess of 100% for a vitronectin receptor antagonist (SB-265123) in rat. II. Studies implicating transporter-mediated intestinal secretion 2004 ·Xenobiotica ·Keith W. Ward,(unknown),Jonathan Kehler,Leonard M. Azzarano,Brian R. Smith	23
14	DEVELOPMENT OF AN IN VIVO PRECLINICAL SCREEN MODEL TO ESTIMATE ABSORPTION AND FIRST-PASS HEPATIC EXTRACTION OF XENOBIOTICS. II. USE OF KETOCONAZOLE TO IDENTIFY P-GLYCOPROTEIN/CYP3A-LIMITED BIOAVAILABILITY IN THE MONKEY 2004 ·Drug Metabolism and Disposition ·Keith W. Ward,(unknown),(unknown),(unknown),Leonard M. Azzarano,Jonathan Kehler,Jeanelle McSurdy-Freed,Joel W. Proksch,Brian R. Smith	37
15	Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models 2001 ·The Journal of Immunology ·Robert S. Ames,Dennis Lee,James J. Foley,Anthony J. Jurewicz,Mark Tornetta,Wilfried Bautsch,(unknown),Andreas Klos,Karl F. Erhard,Russell D. Cousins,Anthony C. Sulpizio,J. Paul Hieble,Gerald P. McCafferty,Keith W. Ward,Jerry L. Adams,William E. Bondinell,David C. Underwood,Ruth R. Osborn,Alison M. Badger,Henry M. Sarau	160
16	Evaluation of the Use of Accelerated Infusions for the Determination of Pharmacokinetic Linearity 2000 ·Journal of Pharmacology and Experimental Therapeutics ·Keith W. Ward,Rian L. Griffiths,Mark A. Levy,Brian R. Smith	5
17	Preclinical Pharmacokinetics and Interspecies Scaling of a Novel Vitronectin Receptor Antagonist 1999 ·Drug Metabolism and Disposition ·Keith W. Ward,Leonard M. Azzarano,William E. Bondinell,Russell D. Cousins,William F. Huffman,Dalia R. Jakas,Richard M. Keenan,Thomas W. Ku,D. Lundberg,William H. Miller,(unknown),K. A. NEWLANDER,(unknown),Theresa J. Roethke,Kevin L. Salyers,(unknown),(unknown),Brian R. Smith	33
18	Development of a Physiologically Based Pharmacokinetic Model to Describe the Disposition of Methanol in Pregnant Rats and Mice 1997 ·Toxicology and Applied Pharmacology ·Keith W. Ward,(unknown),Frank Welsch,Gary M. Pollack	19
19	A pharmacokinetic model of inhaled methanol in humans and comparison to methanol disposition in mice and rats. 1995 ·Environmental Health Perspectives ·(unknown),Keith W. Ward,(unknown)	19

About Keith W. Ward

Keith W. Ward is a scholar working on Ophthalmology, Pharmacology and Pharmacology, having authored 19 papers that have together received 584 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Ocular Surface and Contact Lens (5 papers) and Corneal Surgery and Treatments (4 papers). The work is most often cited by research in Ophthalmology (138 citations), Pharmacology (60 citations) and Immunology (126 citations). Keith W. Ward has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Joel W. Proksch, Karen Harrington, Afshin Shafiee, Brian R. Smith, Claudio Bucolo, Jean-Yves Driot, David J. McCanna, Leonard M. Azzarano, Francisco J. López and Russell D. Cousins. Their work appears in journals such as The Journal of Immunology, Environmental Health Perspectives and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact